Mamiko Tsugawa

Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE)

Tomoya Mita, Naoto Katakami, Toshihiko Shiraiwa et al. · Diabetes Care · 2016 · 141 citations

Medicine, Endocrinology, Pharmacology +17

Tofogliflozin does not delay progression of carotid atherosclerosis in patients with type 2 diabetes: a prospective, randomized, open-label, parallel-group comparative study

Naoto Katakami, Tomoya Mita, Hidenori Yoshii et al. · Cardiovascular Diabetology · 2020 · 73 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

A Patient with Hypocortisolism and Cushing's Syndrome-Like Manifestations: Cortisol Hyperreactive Syndrome*

Sayomi Iida, Yoshihisa Nakamura, Hiroshi Fujii et al. · The Journal of Clinical Endocrinology & Metabolism · 1990 · 61 citations

Life Sciences, Biochemistry, Endocrinology +17

Effect of tofogliflozin on arterial stiffness in patients with type 2 diabetes: prespecified sub-analysis of the prospective, randomized, open-label, parallel-group comparative UTOPIA trial

Naoto Katakami, Tomoya Mita, Hidenori Yoshii et al. · Cardiovascular Diabetology · 2021 · 58 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study

Naoto Katakami, Tomoya Mita, Hidenori Yoshii et al. · Diabetes Therapy · 2017 · 38 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17